Pharmacognostic Characterization and Phytochemical Evaluation of Chrysanthemum Morifolium Flowers with Assessment of Their Anticancer Activity

AIM: The present investigation aimed to establish the pharmacognostical standards, phytochemical composition, total phenolic content, and in vitro anticancer activity of Chrysanthemum morifolium flowers.Methods: Fresh flowers were authenticated, shade-dried, and subjected to detailed macroscopic, microscopic, physicochemical, and phytochemical evaluations according to standard pharmacognostic procedures. Successive solvent extraction was performed using petroleum ether, chloroform, ethanol, and water. The extracts were evaluated for percentage yield, qualitative phytochemical constituents, and total phenolic content using the Folin–Ciocalteu method with gallic acid as the reference standard. Anticancer activity of the extracts was assessed against A549 human lung carcinoma cells using the MTT cell viability assay.Results: Macroscopic and microscopic analyses established the diagnostic characteristics of the flower, while physicochemical parameters confirmed the quality and purity of the crude drug. The loss on drying was 4.5%, with total ash, acid-insoluble ash, and water-soluble ash values of 10.66%, 7.73%, and 3.28%, respectively. Ethanol and aqueous solvents produced the highest extraction yields (15.12% and 15.62%, respectively). Preliminary phytochemical screening revealed abundant phenolics and flavonoids in the ethanol and aqueous extracts, whereas petroleum ether and chloroform extracts contained comparatively fewer bioactive constituents. Quantitative estimation demonstrated that the ethanolic extract possessed the highest total phenolic content (219.86 ± 0.85 mg gallic acid equivalents/g extract), followed by the aqueous extract (148.91 ± 0.31 mg GAE/g). In vitro cytotoxic evaluation exhibited a concentration-dependent inhibition of A549 cell proliferation by all extracts. The ethanolic extract produced the greatest inhibitory activity, achieving 75.63% cell growth inhibition at 1000 μg/mL, followed by the aqueous extract (57.16%), chloroform extract (43.93%), and petroleum ether extract (25.61%). The superior anticancer activity of the ethanolic extract was positively associated with its elevated phenolic and flavonoid content.Conclusion: The findings establish Chrysanthemum morifolium flowers as a valuable source of phenolic-rich phytoconstituents with significant in vitro anticancer potential. The ethanolic extract demonstrated the most promising biological activity, suggesting that phenolic compounds and flavonoids may contribute synergistically to its cytotoxic effects. These results provide pharmacognostic standards for quality control and support further phytochemical isolation, mechanistic investigations, and preclinical studies aimed at developing novel plant-derived anticancer therapeutics.

Authors

Publication Details

Journal
International Journal of Pharmaceutical Research and Applications
Published
2026-11-13
DOI
https://doi.org/10.5281/zenodo.24189063
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pharmacognostic Characterization and Phytochemical Evaluation of Chrysanthemum Morifolium Flowers with Assessment of Their Anticancer Activity

Singh Ms. Nidhi, Yadav Priyanka, Pratap Yadav Dr. Abhay
2 links
International Journal of Pharmaceutical Research and Applications
Medicinal Plant Research
article

Pharmacognostic Characterization and Phytochemical Evaluation of Chrysanthemum Morifolium Flowers with Assessment of Their Anticancer Activity

Singh Ms. Nidhi, Yadav Priyanka, Pratap Yadav Dr. Abhay
article en

Abstract

AIM: The present investigation aimed to establish the pharmacognostical standards, phytochemical composition, total phenolic content, and in vitro anticancer activity of Chrysanthemum morifolium flowers.Methods: Fresh flowers were authenticated, shade-dried, and subjected to detailed macroscopic, microscopic, physicochemical, and phytochemical evaluations according to standard pharmacognostic procedures. Successive solvent extraction was performed using petroleum ether, chloroform, ethanol, and water. The extracts were evaluated for percentage yield, qualitative phytochemical constituents, and total phenolic content using the Folin–Ciocalteu method with gallic acid as the reference standard. Anticancer activity of the extracts was assessed against A549 human lung carcinoma cells using the MTT cell viability assay.Results: Macroscopic and microscopic analyses established the diagnostic characteristics of the flower, while physicochemical parameters confirmed the quality and purity of the crude drug. The loss on drying was 4.5%, with total ash, acid-insoluble ash, and water-soluble ash values of 10.66%, 7.73%, and 3.28%, respectively. Ethanol and aqueous solvents produced the highest extraction yields (15.12% and 15.62%, respectively). Preliminary phytochemical screening revealed abundant phenolics and flavonoids in the ethanol and aqueous extracts, whereas petroleum ether and chloroform extracts contained comparatively fewer bioactive constituents. Quantitative estimation demonstrated that the ethanolic extract possessed the highest total phenolic content (219.86 ± 0.85 mg gallic acid equivalents/g extract), followed by the aqueous extract (148.91 ± 0.31 mg GAE/g). In vitro cytotoxic evaluation exhibited a concentration-dependent inhibition of A549 cell proliferation by all extracts. The ethanolic extract produced the greatest inhibitory activity, achieving 75.63% cell growth inhibition at 1000 μg/mL, followed by the aqueous extract (57.16%), chloroform extract (43.93%), and petroleum ether extract (25.61%). The superior anticancer activity of the ethanolic extract was positively associated with its elevated phenolic and flavonoid content.Conclusion: The findings establish Chrysanthemum morifolium flowers as a valuable source of phenolic-rich phytoconstituents with significant in vitro anticancer potential. The ethanolic extract demonstrated the most promising biological activity, suggesting that phenolic compounds and flavonoids may contribute synergistically to its cytotoxic effects. These results provide pharmacognostic standards for quality control and support further phytochemical isolation, mechanistic investigations, and preclinical studies aimed at developing novel plant-derived anticancer therapeutics.

International Journal of Pharmaceutical Research and Applications
Good health and well-being
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon